222 related articles for article (PubMed ID: 30986573)
1. (±)-trans-Dihydronarciclasine and (±)-trans-dihydrolycoricidine analogues modified in their ring A: Evaluation of their anticancer activity and a SAR study.
Varró G; Pálchuber P; Pogrányi B; Simon A; Hegedűs L; Kádas I
Eur J Med Chem; 2019 Jul; 173():76-89. PubMed ID: 30986573
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.
Lee S; Hwang S; Yu S; Jang W; Lee YM; Kim S
Arch Pharm Res; 2011 Jul; 34(7):1065-70. PubMed ID: 21811912
[TBL] [Abstract][Full Text] [Related]
3. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
4. The First Enantioselective Total Synthesis of (-)-trans-Dihydronarciclasine.
Varró G; Hegedűs L; Simon A; Balogh A; Grün A; Leveles I; Vértessy BG; Kádas I
J Nat Prod; 2017 Jun; 80(6):1909-1917. PubMed ID: 28581297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.
Vshyvenko S; Scattolon J; Hudlicky T; Romero AE; Kornienko A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4750-2. PubMed ID: 21757350
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
7. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.
Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A
Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 454. Synthesis of the strong cancer cell growth inhibitors trans-dihydronarciclasine and 7-deoxy-trans-dihydronarciclasine (1a).
Pettit GR; Ducki S; Eastham SA; Melody N
J Nat Prod; 2009 Jul; 72(7):1279-82. PubMed ID: 19522518
[TBL] [Abstract][Full Text] [Related]
10. Amaryllidaceae and Sceletium alkaloids.
Jin Z
Nat Prod Rep; 2009 Mar; 26(3):363-81. PubMed ID: 19240946
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.
Collins J; Rinner U; Moser M; Hudlicky T; Ghiviriga I; Romero AE; Kornienko A; Ma D; Griffin C; Pandey S
J Org Chem; 2010 May; 75(9):3069-84. PubMed ID: 20373760
[TBL] [Abstract][Full Text] [Related]
12. Amaryllidaceae and Sceletium alkaloids.
Jin Z
Nat Prod Rep; 2007 Aug; 24(4):886-905. PubMed ID: 17653364
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
Li X; Zhao WL; Jiang JD; Ren KH; Du NN; Li YB; Wang YX; Bi CW; Shao RG; Song DQ
Bioorg Med Chem Lett; 2011 Sep; 21(18):5251-4. PubMed ID: 21807514
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of some structural modifications of pancratistatin.
Rinner U; Hillebrenner HL; Adams DR; Hudlicky T; Pettit GR
Bioorg Med Chem Lett; 2004 Jun; 14(11):2911-5. PubMed ID: 15125958
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. 274. A new synthetic strategy for E-ring SAR study of antofine and cryptopleurine analogues.
Yang X; Shi Q; Bastow KF; Lee KH
Org Lett; 2010 Apr; 12(7):1416-9. PubMed ID: 20196574
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative Activity of Amathaspiramide Alkaloids and Analogs.
Shimokawa J; Chiyoda K; Umihara H; Fukuyama T
Chem Pharm Bull (Tokyo); 2016 Aug; 64(8):1239-41. PubMed ID: 27169437
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.
Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T
Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300
[TBL] [Abstract][Full Text] [Related]
18. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
19. synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues.
McNulty J; Nair JJ; Griffin C; Pandey S
J Nat Prod; 2008 Mar; 71(3):357-63. PubMed ID: 18225861
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G
Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
